December 28, 2009

PharmaLegacy is awarded by Pudong Association for Science & Technology, Pudong Human Resource Association and other three organizations with the title of ‘Happiness Generating Workplace’ for its outstanding employee care. For official report of the event please visit http://www.pudong.gov.cn/website/html/shpd/pudongNews_YWYQ/Info/Detail_284875.htm.

November 02, 2009

PharmaLegacy was nominated as a Standing Council Member of Shanghai Society for Biotechnology (website: www.ssbt.org.cn).

October 09,  2009

Dr. Darren Ji will deliver a Keynote Speech titled 'Landscape Overview of China's Life Science Industry'' at BioPartnering China 2.0 on October 14, 2009 in London .

October 1, 2009 PharmaLegacy is Awarded Full Accreditation by AAALAC--

PharmaLegacy Laboratories (Shanghai) Co., Ltd. has been awarded Full Accreditation by AAALAC International’s Council on Accreditation on October 1, 2009. This signifies the institutional commitment to provide quality care and use of lab animals, in regard to the animal welfare stipulated by the AAALAC. ’

September 20, 2009

"The Continuing 58 Years "-- 

PharmaLegacy held an celebration event for Professor Webster Jee on Sept 13, 2009 on the theme of "The Continuing 58 Years". Prof. Jee is a world-known pioneer in bone biology and bone histomorphometry. Professor Jee is a co-founder of PharmaLegacy. About 70 colleagues and friends attended.

September 10, 2009

Drs.Darren Ji and Cheng Jin will attend BioJapan from Oct 7 to 9. BioJapan is a rapidly growing exhibition with a well-organized Business Partner Matching which opens the opportunity to meet all major pharmaceutical companies.

August 25, 2009

Dr. Darren Ji and Desmond Cave will be presenting at BioPartnering Europe in London from October 11-13 as a silver sponsor.

August 13, 2009

Desmond Cave, BSc(Hons),DIBT, was appointed as Director of Business Development Europe. Des brings extensive business experiences to PharmaLegacy, including close to 30 years pharmaceutical development knowledge and 15 years of business development in Europe. Des is based in U.K.

July 13, 2009

Darren Ji, Mei-Shu Shih, Cheng Jin and Peter Liang will represent PharmaLegacy to participate and exhibit at the ASBMR (the American Society for Bone and Mineral Research) 31st Annual Meeting which will be held on September 11-15, 2009 at the Colorado Convention Center in Denver, Colorado, USA. PharmaLegacy’s reception will be held on September 13th with the special celebration of Dr. Webster Jee’s 58 years’ journey in science and his legacy. Around 200 friends and guests are expected to be at the event.

July 11, 2009

Drs. Darren Ji and Mei-Shu Shih attended the 4th International workshop on Advances in the Molecular Pharmacology & Therapeutics of Bone Disease and the International Symposium on Paget’s Disease in Oxford, UK from July 5-10. PharmaLegacy was the sole CRO sponsor of the event.

July 2, 2009

PharmaLegacy and Frontage Announce Service Alliance -- PharmaLegacy Laboratories, Shanghai, China and Frontage Laboratories, Shanghai, China announced the formation of a strategic Alliance to enhance the spectrum of services offered by these two leading CROs.

June 25, 2009

PharmaLegacy exhibited at ChinaBio Partnering Forum 2009 (June 23-24)and Dr. Darren Ji presented at the panel of China’s Outsourcing Revolution.

June 21, 2009

Dr. Darren Ji presented ‘Key Elements in Translating Ideas into Viable Businesses in Life Sciences’ at the 1st Pearl River International Biopharmaceutical Forum & 14th CBA Annual Conference from June 18-20, 2009. PharmaLegacy was also a sponsor of the event.

June 10, 2009

PharmaLegacy will attend BioPartnering China 1.0 as a silver sponsor in Tianjin on June 25, 2009. BioPartnering China is organized by the world leading bio-networking company Technology Vision Group (TVG) which will bring China to the global stage of the life science community in a highly professional and effective way. We envisage that tremendous opportunities could be developed and bridged through this premier conference between China and the world.

June 8, 2009

PharmaLegacy has passed 5 of the world's top 20 pharmaceutical giants’ site accreditation in the recent 3 months. The inspectors are very satisfied with PharmaLegacy’s site quality and have made comments such as: 

   'After looking through the SOPs, I feel like you have been doing GLP for years.’
   'It will take me some time to complete my audit report to my corporation, but I will immediately convey the message that you have passed my audit verbally to  my company’s scientists so that they can start contacting you for study design. ’
   'I have felt the top notch professionalism the moment I walked into your facility, and I am very impressed the caliber of your management team besides your  outstanding design in facility layout.’
   'I was asked by my management to verify the praising words they heard about you. I am telling you that you are impressive and measure up to those praises.’

June 7, 2009

PharmaLegacy Laboratories presented as an annual Silver Corporate Sponsor at Sino-American Biomedical & Pharmaceutical Professionals Association (SABPA) Annual Conference 2009 held on June 6, 2009 in San Diego where Roger Tsien, Professor, UCSD, 2008 Nobel Laureate for Chemistry, presented his up-to-date innovation in his lab to novel medical application. Dr. Jin, as the session chairperson for New Drug Development introduced PharmaLegacy’s CRO business. The Excellency of business is strongly credited and supported by Dr. David Ke, Scientific Executive Director, Amgen being a client, through his presentation in the session.

May 27, 2009

Dr. Peter Liang of PharmaLegacy attended the International Cartilage Repair Society (ICRS) 2009 in Miami from May 23-26, 2009. The ICRS world congress is reaching out to cartilage scientists, surgeons and industry leaders of all nations to share their common interests and passion about cartilage.

May 22, 2009

PharmaLegacy delegation attended the 2009 BIO International Convention held from May 18-21, 2009 in Atlanta, Georgia. The convention was a phenomenal success which brought together thousands of leaders from industry, government, academia and other disciplines who are working to solve some of society’s greatest challenges.

May 17, 2009

PharmaLegacy Laboratories presented as an annual Silver Sponsor at SAPA-GP and Monte Jade Annual Conference 2009 held in Philadelphia from May 15-16, 2009. Dr. Darren Ji, as a featured speaker, made a speech titled Key Elements in Translating Ideas into Viable Businesses in Life Sciences.

March 12, 2009

PharmaLegacy Laboratories will be exhibiting at 100th American Association for Cancer Research (AACR) Annual Meeting. The centennial meeting will be held from April 18-22, 2009 at Colorado Convention Center, Denver, CO. Please visit us (Booth # 1064) at this premier meeting for specialists in the cancer research field. Our expert scientists look forward to interacting with you in person and build your product competitiveness in the marketplace with our world class pre-clinical services.

February 18, 2009

PharmaLegacy and Venturepharm Announce Service Alliance -- Dr. Darren Ji, CEO of PharmaLegacy Laboratories, Shanghai, China and Dr. Bill Guo, CEO of Venturepharm China announced the formation of a strategic Alliance to enhance the spectrum of services offered by these two leading CROs. Announcement

January 24, 2009

PharmaLegacy will showcase its high quality service capabilities at the Orthopedic Research Society Meeting, to be held at Las Vegas, Nevada, Feb 22-25, 2009. Dr. Mei-Shu Shih, CSO of PharmaLegacy will be attending the meeting.

January 20, 2009

PharmaLegacy announced today that it will host a Workshop entitled: “R&D Outsourcing to China, a Quick Fix or a Defendable Solution?” at the BioPartnering North America to be held a Vancouver, Canada, Feb 8-10, 2009.

January 18, 2009

Dr. Darren Ji was invited to join the China Advisory Committee of BioPartnering China (BPC), jointly organized by Technology Vision Group (California, US) and European Federation of Biotechnology. Dr. Ji will present at the BPC panel at the BioPartnering North America (Vancouver, Canada), Feb 8-10, 2009.

January 9, 2009

PharmaLegacy announced today the signing of a master service agreement with a dominant medical device company to provide in vivo testing services. Dr. Darren Ji, CEO of PharmaLegacy, said: “To be entrusted by one of the world’s top players in the medical device field is an excellent acknowledgement of our high quality services. We strive to help our clients to achieve their goals faster, better, and cost-effectively”.